# Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase

> **NCT05926128** · NA · UNKNOWN · sponsor: **Fundaleu** · enrollment: 75 (estimated)

## Conditions studied

- CML

## Interventions

- **DRUG:** Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment

## Key facts

- **NCT ID:** NCT05926128
- **Lead sponsor:** Fundaleu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2025-01
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926128, "Study of Treatment Free Remission in Patients With Chronic Myeloid Leukemia in Chronic Phase". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05926128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*